Profile
Shawnalea Frazier currently works at AbbVie Ventures LLC, as Director from 2023.
Dr. Frazier also formerly worked at Novo Ventures (US), Inc., as Principal from 2020 to 2022.
Dr. Frazier received her undergraduate degree and graduate degree from Kansas State University and doctorate degree in 2012 from California Institute of Technology.
Shawnalea Frazier active positions
| Companies | Position | Start |
|---|---|---|
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures invests in companies located in the United States and Europe. The firm focuses on healthcare sectors such as oncology, immunology, neuroscience, obesity, eye care and aesthetics. It participates in seed and early-stage transactions. It acts as lead and co-lead investor. | Private Equity Investor | 31/07/2023 |
Former positions of Shawnalea Frazier
| Companies | Position | End |
|---|---|---|
Novo Ventures (US), Inc.
Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | Private Equity Analyst | 30/11/2019 |
Training of Shawnalea Frazier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Kansas State University
Kansas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Ventures (US), Inc.
Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world. | Finance |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures invests in companies located in the United States and Europe. The firm focuses on healthcare sectors such as oncology, immunology, neuroscience, obesity, eye care and aesthetics. It participates in seed and early-stage transactions. It acts as lead and co-lead investor. | Finance |
- Stock Market
- Insiders
- Shawnalea Frazier
















